In addition, Sun et al. reported that serum ORM1 expression was decreased in non-small cell lung cancer patients, which was in accordance with the results of a study by Jia et al. [13], supporting the application of ORM1 as a biomarker [24]. The gene discussed is ORM1; the disease is non-small cell lung carcinoma.